Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 5:05 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1489–1512 of 48,494 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: AS+ Clear all

Conditions: Acute Myocardial Infarction (AMI)
Interventions: Not listed
Lead sponsor: Rohan Dharmakumar; Other
Eligibility: 18 Years to 79 Years
Enrollment: 312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Dystonia
Interventions: incobotulinumtoxin A, Placebo; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 80 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 2
States / cities: New York, New York

Conditions: Keratoconus
Interventions: Intacs; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2030
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Parkinson's Disease
Interventions: non-invasive cervical vagal nerve stimulation ncVNS; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 50 Years to 88 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Hines, Illinois

Conditions: Obstructive Sleep Apnea, Sleep Apnea
Interventions: ProSomnus® EVO Sleep and Snore Device; Device
Lead sponsor: ProSomnus Sleep Technologies; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 5
States / cities: Redwood City, California • Boston, Massachusetts • Minneapolis, Minnesota + 2 more

Conditions: ACL Tear
Interventions: NMES and BFR, Standard physical therapy; Other
Lead sponsor: Stanford University; Other
Eligibility: 13 Years to 17 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Sunnyvale, California

Conditions: Myelodysplastic Syndromes (MDS)
Interventions: venetoclax, azacitidine; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 10
States / cities: Tucson, Arizona • Aurora, Colorado • New Haven, Connecticut + 6 more

Conditions: Cognitive Dysfunction, Alzheimer Disease, Blood-Brain Barrier, Apolipoprotein E, Deficiency or Defect of, Brain Aging, Fatty Acids, Omega-3
Interventions: Alpha-Linolenic Acid (2.6 g/day), Placebo Control Group; Drug · Dietary Supplement
Lead sponsor: Michal Schnaider Beeri, Ph.D.; Other
Eligibility: 60 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Light Chain Deposition Disease, Primary Systemic Amyloidosis
Interventions: pomalidomide, bortezomib, dexamethasone, Laboratory Biomarker Analysis; Drug · Other
Lead sponsor: Barbara Ann Karmanos Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 4
States / cities: Denver, Colorado • Boston, Massachusetts • Detroit, Michigan + 1 more

Conditions: Celiac Disease
Interventions: Not listed
Lead sponsor: Celgene; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Dallas, Texas • Seattle, Washington

Conditions: Irrigation
Interventions: Lactated Ringer's Irrigation, Normal Saline; Drug
Lead sponsor: Carl Snyderman; Other
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Endometrial Adenocarcinoma
Interventions: ACR-368, Gemcitabine, OncoSignature; Drug · Diagnostic Test
Lead sponsor: Acrivon Therapeutics; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 69
States / cities: Mobile, Alabama • Anchorage, Alaska • Phoenix, Arizona + 56 more

Conditions: Osteoarthritis, Arthritis
Interventions: Negative Work, Stretching; Other
Lead sponsor: Washington D.C. Veterans Affairs Medical Center; Federal
Eligibility: 50 Years to 70 Years · Male only
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Thyroid, PD-1, Cancer
Interventions: blood draw and questionnaire completion, questionnaire completion, blood collection; Other
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Alcohol Use Disorder
Interventions: Standard treatment (ST) PLUS web-based CBT4CBT, Standard Treatment (ST); Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 5
States / cities: Bridgeport, Connecticut • New Haven, Connecticut

Conditions: Irritable Bowel Syndrome, Bacterial Overgrowth Syndrome, SIBO
Interventions: Atrantil (Medical Food); Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Bacterial Infection, Multiple-drug Resistance, Pathogen Resistance
Interventions: Fosfomycin disodium; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Infertility, Pregnancy Outcome, Live Birth, In Vitro Fertilization
Interventions: 10% SSS embryo culture medium protein supplementation, 0.5% HSA embryo culture medium protein supplementation; Other
Lead sponsor: Texas Health Resources; Other
Eligibility: 20 Years to 40 Years · Female only
Enrollment: 538 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2003
U.S. locations: 2
States / cities: Dallas, Texas • Plano, Texas

Conditions: Obesity, Childhood, Metabolic Syndrome
Interventions: FIT, Home-Based Family Support; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 12 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Stretch Marks, Striae Distensae, Cosmetic Appearance of Stretch Marks
Interventions: Placebo Vehicle Cream, Centella Asiatica Cream; Other
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years and older · Female only
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Hypertension, Cardiovascular Diseases, Diabetes
Interventions: Herbiotics Oral + Ent Probiotic, Placebo; Dietary Supplement
Lead sponsor: Wake Forest University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Opioid Overdose
Interventions: Organize and Mobilize for Implementation Effectiveness, Dissemination; Other
Lead sponsor: RTI International; Other
Eligibility: 18 Years and older
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Major Depressive Disorder
Interventions: Ketamine infusion, Midazolam infusion; Drug
Lead sponsor: Yale University; Other
Eligibility: 13 Years to 17 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Mild Cognitive Impairment (MCI), Cognition, Brain Aging, Microbiome Dysbiosis, Leaky Gut Syndrome, Gut Inflammation, Inflammaging
Interventions: LpD3.5, Placebo; Dietary Supplement
Lead sponsor: University of South Florida; Other
Eligibility: 60 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Tampa, Florida

Search by objective public record fields.

Acute MI UDMI Staging Diagnosis by High-sensitivity Cardiac Troponin-I

Incobotulinum Toxin A (Xeomin®) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand

Intacs Prescription Inserts for Keratoconus Patients

Non-invasive VNS for Parkinson's Gait

Severe OSA Study (SOS)

Quadriceps Strengthening ACL Reconstruction

A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Participants With Relapsed/Refractory Myelodysplastic Syndromes (MDS)

ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults

First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD

A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease

Evaluation of Endoscopic Surgical Field Clarity Using Hot Saline Versus Lactated Ringer's Irrigation

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Negative Work Exercise for the Treatment of Knee Arthritis

Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors

CBT4CBT With Spanish Alcohol Users

Atrantil for Intestinal Bacterial Overgrowth

Intravenous Fosfomycin Pharmacokinetics Study

in Vitro Fertilization (IVF) Media Protein and Live Birth Rates

FIT Families Multicomponent Obesity Intervention for African American Adolescents

Topical Centella Asiatica and the Cosmetic Appearance of Stretch Marks

Probiotic Effect on Dietary Nitrate to Plasma Nitrite Production ( OPEDNPN )

Preventing Opioid Overdose Mortality in the United States

Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy

LpD3.5 Intervention Study in Older Adults- LISA-I Trial